New hope in treating PTSD with psychedelic drugs
Rachel Yehuda, PhD, discusses how some service members and others suffering from post-traumatic stress disorder (PTSD) are finding promising results in a recent United States Food and Drug Administration-approved trial using a psychedelic drug called MDMA–better known by its street name, ecstasy.
Press Release
Stem Cell Study Reveals How Neurons From PTSD Patients React to Stress
Oct 20, 2022 View All Press Releases
